Skip to content
★ Sign in to follow
MA

Michael A. DesJardin

Vice-Président Exécutif des Opérations Techniques
Horizon Therapeutics Public Ltd CoJazz Pharmaceuticals plc
Total declarations
70
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€10.6M

Latest filing published 06 Oct 2023 for Horizon Therapeutics Public Ltd Co, €14.0M.

Filing timeline

BuySale
Michael A. DesJardin

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Michael A. DesJardin: trading record in brief

Michael A. DesJardin (senior executive) discloses dealings in 2 companies, chiefly Horizon Therapeutics Public Ltd Co and Jazz Pharmaceuticals plc. We count 70 filings; the first trade dates from 31 May 2011 and the latest from 6 October 2023.

The open-market record consists of 14 sales worth €10.6M, with no purchase. The rest of the record consists of 32 share grants and 22 option exercises.

The newest entry dates from 6 October 2023: a transaction of €14.0M, in Horizon Therapeutics Public Ltd Co. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Michael A. DesJardin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations70 total

25 of 70 declarations